Compounds > valine

valine and Cerebral Infarction

valine has been researched along with Cerebral Infarction in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, Y; Nakajima, M; Namitome, S; Shindo, S; Terasaki, T; Wada, K1
Hernesniemi, JA; Juvela, S; Kanarek, K; Lappalainen, J; Siironen, J; Vilkki, J1
Bai, Y; Chen, L; Li, L; Qi, J; Qi, Z; Sun, K; Yang, R; Zhang, Z; Zhou, L1
Chujo, M; Hashimoto, T; Ishigaki, M; Kohro, T; Yamazaki, T1
Akar, N; Deda, G; Dönmez, B1
Baron, BM; Fisher, M; Hasegawa, Y; Metcalf, G1
Baron, BM; Chopp, M; Jiang, N; Zhang, RL1

Trials

1 trial(s) available for valine and Cerebral Infarction

ArticleYear
Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.
    Neurosurgery, 2008, Volume: 63, Issue:2

    Topics: Adult; Alleles; Brain-Derived Neurotrophic Factor; Cerebral Infarction; Female; Humans; Male; Memory; Memory Disorders; Methionine; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Subarachnoid Hemorrhage; Valine

2008

Other Studies

6 other study(ies) available for valine and Cerebral Infarction

ArticleYear
[Cerebral infarction related to varicella zoster virus vasculopathy].
    Rinsho shinkeigaku = Clinical neurology, 2018, Mar-28, Volume: 58, Issue:3

    Topics: Acyclovir; Adolescent; Antibodies, Viral; Antiviral Agents; Biomarkers; Brain; Cerebral Infarction; Drug Therapy, Combination; Female; Fibrinolytic Agents; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Valacyclovir; Valine

2018
Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analysis of Variance; Animals; Brain Ischemia; Calcium; Cerebral Infarction; Cerebrosides; Charybdotoxin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glucose; Glutamic Acid; Hippocampus; Hypoxia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tetrazolium Salts; Valine

2012
The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID).
    Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:2

    Topics: Aged; Angina Pectoris; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Disorders; Female; Health Surveys; Heart Failure; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Retrospective Studies; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan

2013
FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
    Journal of child neurology, 2007, Volume: 22, Issue:2

    Topics: Adolescent; Cerebral Infarction; Child; Child, Preschool; DNA Mutational Analysis; Factor XIII; Female; Humans; Infant; Leucine; Male; Polymorphism, Genetic; Turkey; Valine

2007
The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
    Stroke, 1994, Volume: 25, Issue:6

    Topics: Animals; Blood Pressure; Body Temperature; Brain; Carbon Dioxide; Cerebral Arteries; Cerebral Infarction; Infusion Pumps; Injections, Intravenous; Ischemic Attack, Transient; Male; N-Methylaspartate; Pilot Projects; Placebos; Rats; Rats, Sprague-Dawley; Valine

1994
Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
    Journal of the neurological sciences, 1996, Volume: 138, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Valine

1996